Remnant Cholesterol as a Residual Risk in Patients With Atherosclerotic Cardiovascular Disease Under ModerateIntensity Statin With Ezetimibe Combination Therapy or HighIntensity Statin Monotherapy

被引：0
|
作者：
Lee, Jung-Hee [1 ]
Ahn, Sung Gyun [2 ]
Lee, Seung-Jun [3 ]
Hong, Sung-Jin [4 ]
Ahn, Chul-Min [5 ]
Ko, Young-Guk [6 ]
Kim, Jung-Sun [5 ]
Choi, Donghoon [7 ]
Hong, Myeong-Ki [8 ]
Jang, Yangsoo [9 ]
Kim, Byeong-Keuk [3 ]
机构：
[1] Wonju Severance Christian Hosp, Wonju, South Korea
[2] Yonsei Univ, Wonju Coll Med, Wonju, South Korea
[3] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea
[4] Yonsei Univ, Severance Hosp, Seoul, South Korea
[5] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea
[6] Yonsei Univ, Seoul, South Korea
[7] Severance Hosp, Seoul, South Korea
[8] Yonsei Univ, Coll Med, Seoul, South Korea
[9] CHA Univ, CHA Bundang Med Ctr, Sch Med, Bundang, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 82卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-249
引用
收藏
页码：B97 / B98
页数：2
相关论文
共 50 条
  • [41] Reducing residual risk for patients on statin therapy: The potential role of combination therapy
    Davidson, MH
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (9A): : 3K - 13K
  • [42] Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy
    Mihaylova, B.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1054 - 1054
  • [43] Predictors of Residual Cardiovascular Risk in Patients on Statin Therapy for Primary Prevention
    Afonso, Luis
    Veeranna, Vikas
    Zalawadiya, Sandip
    Ramesh, Krithi
    Niraj, Ashutosh
    Panaich, Sidakpal
    CARDIOLOGY, 2011, 119 (04) : 187 - 190
  • [44] Predictors of Residual Cardiovascular Risk in Patients on Statin Therapy for Primary Prevention
    Veeranna, Vikas
    Zalawadiya, Sandip
    Ramesh, Krithi
    Niraj, Ashutosh
    Pradhan, Jyotiranjan
    Afonso, Luis
    CIRCULATION, 2010, 122 (21)
  • [45] Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease
    Wong, Nathan D.
    Zhao, Yanglu
    Xiang, Pin
    Coll, Blai
    Lopez, J. Antonio G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 137 : 7 - 11
  • [46] MARKOV MODEL-BASED ECONOMIC EVALUATION OF COMBINATION THERAPY WITH EZETIMIBE AND STATIN MONOTHERAPY
    Pan, D.
    VALUE IN HEALTH, 2014, 17 (07) : A761 - A761
  • [47] Comparison of Efficacy and Safety of Statin-Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies
    Shin, Kwang-Hee
    Choi, Hye Duck
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (04) : 395 - 406
  • [48] Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial (vol 8, pg 853, 2023)
    Lee, S. J.
    Cha, J. J.
    Choi, W. G.
    JAMA CARDIOLOGY, 2023, 8 (09) : 891 - 891
  • [49] Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease
    Rodriguez, Fatima
    Maron, David J.
    Knowles, Joshua W.
    Virani, Salim S.
    Lin, Shoutzu
    Heidenreich, Paul A.
    JAMA CARDIOLOGY, 2017, 2 (01) : 47 - 54
  • [50] Trends in Statin Therapy for the Secondary Prevention in Dialysis Patients With Atherosclerotic Cardiovascular Disease
    Lee, Myunhee
    Kim, Do Young
    Hong, Yu Ah
    Park, Mahn Won
    Kim, Dae-Won
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B222 - B222
12345